Impact of postnatal steroids on peripheral avascular retina and severity of retinopathy of prematurity
- PMID: 37291231
- DOI: 10.1038/s41390-023-02673-4
Impact of postnatal steroids on peripheral avascular retina and severity of retinopathy of prematurity
Abstract
Background: We investigated the role of postnatal steroids on the severity of retinopathy of prematurity (ROP) and its impact on peripheral avascular retina (PAR).
Methods: A retrospective cohort study of infants born at ≤32 weeks gestation and/or birth weight ≤1500 g. Demographics, the dose and duration of steroid treatment, and age when full retinal vascularization occurred were collected. The primary outcomes were the severity of ROP and time to full vascularization of the retina.
Results: A total of 1695 patients were enrolled, 67% of whom received steroid therapy. Their birth weight was 1142 ± 396 g and gestational age was 28.6 ± 2.7 weeks. The total hydrocortisone-equivalent dose prescribed was 28.5 ± 74.3 mg/kg. The total days of steroid treatment were 8.9 ± 35.1 days. After correction for major demographic differences, infants who received a higher cumulative dose of steroids for a longer duration had a significantly increased incidence of severe ROP and PAR (P < 0.001). For each day of steroid treatment, there was a 3.2% increase in the hazard of the severe form of ROP (95% CI: 1.022-1.043) along with 5.7% delay in achieving full retinal vascularization (95% CI: 1.04-1.08) (P < 0.001).
Conclusion: Cumulative dose and duration of postnatal steroid use were independently associated with the severity of ROP and PAR. Thus, postnatal steroids should be used very prudently.
Impact: We report ROP outcomes in a large cohort of infants from two major healthcare systems where we have studied the impact of postnatal steroids on the severity of ROP, growth, and development of retinal vessels. After correcting our data for three major outcome measures, we show that high-dose postnatal steroids used for a prolonged duration of time are independently associated with severe ROP and delay in retinal vascularization. Postnatal steroids impact the visual outcomes of VLBW infants significantly, so their clinical use needs to be moderated.
© 2023. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Similar articles
-
Postnatal administration of systemic steroids increases severity of retinopathy in premature infants.Pediatr Neonatol. 2022 May;63(3):220-226. doi: 10.1016/j.pedneo.2021.09.005. Epub 2021 Nov 20. Pediatr Neonatol. 2022. PMID: 34879992
-
RATE OF AND TIME TO COMPLETE RETINAL VASCULARIZATION IN PREMATURE INFANTS AND ASSOCIATED FACTORS.Retina. 2023 Jan 1;43(1):102-110. doi: 10.1097/IAE.0000000000003627. Retina. 2023. PMID: 36201755
-
Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.J Perinatol. 2001 Jun;21(4):242-7. doi: 10.1038/sj.jp.7200531. J Perinatol. 2001. PMID: 11533841
-
Persistent avascular retina in retinopathy of prematurity.Graefes Arch Clin Exp Ophthalmol. 2025 Apr 3. doi: 10.1007/s00417-025-06820-x. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40178600 Review.
-
Retinal, visual, and refractive development in retinopathy of prematurity.Eye Brain. 2016 May 20;8:103-111. doi: 10.2147/EB.S95021. eCollection 2016. Eye Brain. 2016. PMID: 28539805 Free PMC article. Review.
Cited by
-
Retinopathy of Prematurity-Targeting Hypoxic and Redox Signaling Pathways.Antioxidants (Basel). 2024 Jan 25;13(2):148. doi: 10.3390/antiox13020148. Antioxidants (Basel). 2024. PMID: 38397746 Free PMC article. Review.
-
Association between Early Postnatal Hydrocortisone and Retinopathy of Prematurity in Extremely Preterm Infants.Neonatology. 2025;122(3):329-338. doi: 10.1159/000543659. Epub 2025 Jan 21. Neonatology. 2025. PMID: 39837291 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources